Alkhawaja Safaa, Saeed Nermeen Kamal, Rosenthal Victor Daniel, Abdul-Aziz Sana, Alsayegh Ameena, Humood Zainab Mahdi, Ali Khadija Mohamed, Swar Saleh, Magray Tahira Anwar Saeed
Salmaniya Medical Center, Ministry of Health, Manama, Bahrain.
International Nosocomial Infection Control Consortium, Buenos Aires, Argentina.
J Vasc Access. 2020 Jul;21(4):481-489. doi: 10.1177/1129729819888426. Epub 2019 Dec 10.
Central line-associated bloodstream infections are serious life-threatening infections in the intensive care unit setting.
To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection rates in Bahrain from January 2013 to December 2016, we conducted a prospective, before-after surveillance, cohort, observational study in one intensive care unit in Bahrain. During baseline, we performed outcome and process surveillance of central line-associated bloodstream infection on 2320 intensive care unit patients, applying Centers for Disease Control and Prevention's National Healthcare Safety Network definitions. During intervention, we implemented IMA through ISOS, including (1) a bundle of infection prevention interventions, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback on central line-associated bloodstream infection rates and consequences, and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using a logistic regression model to estimate the effect of the intervention on the central line-associated bloodstream infection rate.
During baseline, 672 central line days and 7 central line-associated bloodstream infections were recorded, accounting for 10.4 central line-associated bloodstream infections per 1000 central line days. During intervention, 13,020 central line days and 48 central line-associated bloodstream infections were recorded. After the second year, there was a sustained 89% cumulative central line-associated bloodstream infection rate reduction to 1.2 central line-associated bloodstream infections per 1000 central line days (incidence density rate, 0.11; 95% confidence interval 0.1-0.3; p, 0.001). The average extra length of stay of patients with central line-associated bloodstream infection was 23.3 days, and due to the reduction of central line-associated bloodstream infections, 367 days of hospitalization were saved, amounting to a reduction in hospitalization costs of US$1,100,553.
Implementing IMA was associated with a significant reduction in the central line-associated bloodstream infection rate in Bahrain.
中心静脉导管相关血流感染是重症监护病房中严重威胁生命的感染。
为分析国际医院感染控制联盟(INICC)多维方法(IMA)和INICC在线监测系统(ISOS)对2013年1月至2016年12月巴林中心静脉导管相关血流感染率的影响,我们在巴林的一个重症监护病房进行了一项前瞻性、前后对照监测、队列观察性研究。在基线期,我们根据疾病控制与预防中心的国家医疗安全网络定义,对2320例重症监护病房患者进行了中心静脉导管相关血流感染的结局和过程监测。在干预期,我们通过ISOS实施IMA,包括(1)一系列感染预防干预措施,(2)教育,(3)结局监测,(4)过程监测,(5)关于中心静脉导管相关血流感染率及后果的反馈,以及(6)过程监测的绩效反馈。使用逻辑回归模型进行双变量和多变量回归分析,以评估干预对中心静脉导管相关血流感染率的影响。
在基线期,记录了672个中心静脉导管日和7例中心静脉导管相关血流感染,每1000个中心静脉导管日的中心静脉导管相关血流感染率为10.4例。在干预期,记录了13020个中心静脉导管日和48例中心静脉导管相关血流感染。在第二年之后,中心静脉导管相关血流感染率持续累积降低89%,降至每1000个中心静脉导管日1.2例中心静脉导管相关血流感染(发病密度率,0.11;95%置信区间0.1 - 0.3;p < 0.001)。中心静脉导管相关血流感染患者的平均额外住院天数为23.3天,由于中心静脉导管相关血流感染的减少,节省了367个住院日,住院费用减少了1,100,553美元。
在巴林实施IMA与中心静脉导管相关血流感染率的显著降低相关。